Science Daily - "Mount Sinai Finds That Oral Immunotherapy Shows Promise As Treatment For Children With Egg Allergy"

 – July 18, 2012 /Press Release/  –– 

A team of researchers from Mount Sinai School of Medicine and four other institutions have found that young children with egg allergies can benefit from treatment with oral immunotherapy. "After 10 months of therapy, 55 percent of those who received oral immunotherapy passed the oral food challenge and were considered to be desensitized, compared to none of those on placebo," said Scott Sicherer, MD, Professor of Pediatrics and Chief of the Division of Allergy and Immunology at Mount Sinai School of Medicine. In the oral-immunotherapy group, 28 percent of the children passed the oral food challenge at 24 months after being off daily therapy for four to six weeks and were considered to no longer have an allergy to egg. "We found that oral immunotherapy provides protection in a majority of children with egg allergy by raising the reaction threshold," said Hugh Sampson, MD, Dean for Translational Biomedical Sciences, Professor of Pediatrics, and Director of the Jaffe Food Allergy Institute at Mount Sinai School of Medicine. Learn more